Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Non-Current Deffered Revenue (2016 - 2019)

Forte Biosciences (FBRX) has disclosed Non-Current Deffered Revenue for 4 consecutive years, with $2.3 million as the latest value for Q1 2019.

  • On a quarterly basis, Non-Current Deffered Revenue rose 1336.88% to $2.3 million in Q1 2019 year-over-year; TTM through Mar 2019 was $2.3 million, a 1336.88% increase, with the full-year FY2018 number at $2.2 million, up 6013.89% from a year prior.
  • Non-Current Deffered Revenue was $2.3 million for Q1 2019 at Forte Biosciences, up from $2.2 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $2.3 million in Q1 2019 to a low of $9000.0 in Q3 2018.
  • A 4-year average of $647600.0 and a median of $64500.0 in 2016 define the central range for Non-Current Deffered Revenue.
  • Biggest YoY gain for Non-Current Deffered Revenue was 6013.89% in 2018; the steepest drop was 78.05% in 2018.
  • Forte Biosciences' Non-Current Deffered Revenue stood at $68000.0 in 2016, then plummeted by 47.06% to $36000.0 in 2017, then soared by 6013.89% to $2.2 million in 2018, then increased by 4.45% to $2.3 million in 2019.
  • Per Business Quant, the three most recent readings for FBRX's Non-Current Deffered Revenue are $2.3 million (Q1 2019), $2.2 million (Q4 2018), and $9000.0 (Q3 2018).